Azhar Zafar

Has grant

Senior Lecturer

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Azhar Zafar is a Senior Lecturer at The University of Buckingham Medical School in the UK. His research primarily focuses on primary care interventions, including the assessment of medication co-prescription, the impact of telemedicine on diabetic screening, and the effectiveness of treatments for depressive symptoms. He has contributed to numerous studies investigating cardiovascular risk, anxiety treatments, and the effectiveness of health check programs in a clinical setting.

Recent Grants

Grant: Close

Acknowledging and allocating the Responsibility of Clinical Inertia in the management of T2DM

Open Date: 2011-11-01

Close Date: 2013-10-01

Grant: Close

NIHR in Practice fellowship

Open Date: 2008-07-01

Close Date: 2010-10-01

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (17)

Melissa Dobson

University of Oxford

UNITED KINGDOM

Azhar Zafar

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

Opportunities and challenges to delivering a trial for depressive symptoms in primary care during the COVID-19 pandemic: insights from the Alpha-Stim-D randomised controlled trial.

Assessing Gastro-Protective Medication Co-Prescription with NSAIDs, Anticoagulants, and Antiplatelets in Primary Care: An audit

Polygenic risk score adds to a clinical risk score in the prediction of cardiovascular disease in a clinical setting

Telemedicine in Diabetic Retinal Screening: Pre- and Post-COVID-19 Challenges a New Perspective

Transcranial Direct Current Stimulation (tDCS) for Depression Treatment in a Primary Healthcare General Practice&amp;#8212;An Open-Label Cohort Study Measuring Montgomery-&amp;#197;sberg Depression Rating Scale (MADRS-S) Outcomes

Alpha-Stim AID cranial electrotherapy stimulation (CES) anxiety treatment

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Evaluating the clinical effectiveness of the NHS Health Check programme: a prospective analysis in the Genetics and Vascular Health Check (GENVASC) study

Urine ACR uptake in patients with a diagnosis of type 1 and 2 diabetes mellitus in a primary care setting: A cross sectional study.

Clinical effectiveness of active Alpha-Stim AID versus sham Alpha-Stim AID in major depression in primary care in England (Alpha-Stim-D): a multicentre, parallel group, double-blind, randomised controlled trial

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

A randomised controlled trial investigating the clinical and cost-effectiveness of Alpha-Stim AID cranial electrotherapy stimulation (CES) in patients seeking treatment for moderate severity depression in primary care (Alpha-Stim-D Trial).

Alpha-Stim Cranial Electrotherapy Stimulation (CES) for Anxiety Treatment: Outcomes in a United Kingdom (UK) Primary Care Practice

Collaborators (17)

Melissa Dobson

Philip Evans

Jienchi Dorward

Radoslaw Debiec

Jane Holmes

Simon Royal

Paul Briley

Priya Patel

Jon Dickson

Mark Lown

Charley Budgeon

Duncan Richards

Boliang Guo

Vibhore Prasad

Ksenija Maravic da Silva

Haroon Ahmed

Najib M Rahman

Make your next move.

Transcranial Direct Current Stimulation (tDCS) for Depression Treatment in a Primary Healthcare General Practice—An Open-Label Cohort Study Measuring Montgomery-Åsberg Depression Rating Scale (MADRS-S) Outcomes